|4Apr 25, 6:54 PM ET

Marango Jotin 4

4 · Ikena Oncology, Inc. · Filed Apr 25, 2022

Insider Transaction Report

Form 4
Period: 2022-04-25
Marango Jotin
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-04-25+397,199397,199 total
    Exercise: $5.88Exp: 2032-04-25Common Stock (397,199 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to this option shall vest and become exercisable on April 25, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION